The combination group included those who added a newer generation GLP-1RA (i.e., exenatide once weekly [OW], dulaglutide, semaglutide OW T2D, or oral semaglutide) or dual GLP-1/GIP agonist (tirzepatide T2D) to their SGLT2i (i.e., canagliflozin, dapagliflozin, empagliflozin, ertugliflozin, or bexagliflozin) treatment, with persistent use of a GLP-1RA and SGLT2i for 180 days each and an overlap 120 days, where the gap after exhaustion of days supply was required to be 30 days

TIER 0 (20mg total) $235 total for 10 week supply Monthly cost breakdown: $94 Recommended if using low (or micro) doses of 2mg/week or less TIER 1 (40mg total) $325 total for 8-10 week supply Monthly cost breakdown: $130-$162 based on weekly dose Recommended if new to treatment or for those on 2-5mg/week TIER 2 (60mg total) $340 total for 8-10 week supply Monthly cost breakdown: $136-$170 based on weekly dose Recommended for those on 6-7mg/week TIER 3 (90mg total) $380 total for 9-10 week supply Monthly cost breakdown: $152-$168 based on weekly dose Recommended for those on 8-10mg/week TIER 4 (120mg total) $395 total for 8-10 week supply Monthly cost breakdown: $158-$197 based on weekly dose Recommended for those on 11mg/week and up Boudreaux Pharmacy - Tirzepatide/Glycine Injection (NEW) Up to 90 days BUD
While some patients - around 40% - report mild to moderate gastrointestinal side effects, only about 5% discontinue treatment due to these issues
And since the May 2025 deadline has already passed, healthcare professionals recommend acting now rather than waiting until your supply runs out
Both edibles and tinctures avoid the lung-related risks associated with smoking marijuana
What Comes Next The most appropriate next step is not immediate routine use of GLP-1 receptor agonists as a breast cancer outcome intervention